About 141,000 results
Open links in new tab
  1. LAIs Tied to Lower Relapse, Mortality Risk in Schizophrenia

    Oct 16, 2025 · Long-acting injectable antipsychotics are linked to a lower risk for disease relapse and mortality than oral antipsychotics in adults with schizophrenia, a new study shows.

  2. Forget the Tremor: These Symptoms Come First in Parkinson’s

    Jun 10, 2025 · It often appears alongside other signs like a softer, monotone voice or reduced arm swing while walking — both early signs of extrapyramidal dysfunction.

  3. Metoclopramide in the Treatment of Diabetic Gastroparesis

    Acute Dystonic Reactions Acute dystonic reactions are the most frequent extrapyramidal side effects (EPS) from metoclopramide and typically occur within 24–48 h of initiating treatment, …

  4. What drives antipsychotic adherence in first psychosis? - Medscape

    Nuance in sexual, extrapyramidal side effects, onset of action can make or break antipsychotic adherence.

  5. Untreated Tardive Dyskinesia Hinders Use of Antipsychotics

    Jul 29, 2024 · Tardive dyskinesia, often underdiagnosed and undertreated, hinders patient adherence to antipsychotics, affecting mental health treatment and caregivers' well …

  6. New Management Approaches for Gastroparesis - Page 4

    It has the advantage of either parenteral (including subcutaneous) or oral dosing, but side effects including extrapyramidal reactions are not uncommon. [43] Tardive dyskinesia represents a ...

  7. Novel Drug Safe, Effective for Acute Schizophrenia - Medscape

    May 23, 2025 · The novel PDE10A inhibitor CPL'36 offers a new mechanism of action and is both safe and effective for acute exacerbations of schizophrenia, new research suggests.

  8. Clinical Differences Among Four Common Dementia Syndromes

    Secondly, individuals with DLB usually have extrapyramidal signs in axial structures such as postural instability and masked face, whereas tremor is less prominent than among those with …

  9. Ending Long-term Anticholinergic Use: It Can Be Done - Medscape

    Jun 3, 2020 · Ending the common, but unsanctioned, practice of long-term anticholinergic use to head off extrapyramidal symptoms (EPS) associated with antipsychotic medications in patients …

  10. Olanzapine Associated With Lower Rate of Extrapyramidal

    Oct. 2, 2003 — Olanzapine was associated with the fewest patients with extrapyramidal symptoms (EPS) at six months compared with baseline, according to the results of a large …